🇺🇸 FDA
Pipeline program

XB2001 or Placebo

2020-PT049

Phase 2 mab active

Quick answer

XB2001 or Placebo for Pancreatic Cancer is a Phase 2 program (mab) at XBiotech with 1 ClinicalTrials.gov record(s).

Program details

Company
XBiotech
Indication
Pancreatic Cancer
Phase
Phase 2
Modality
mab
Status
active

Clinical trials